USA - engelsk - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - mebendazole (unii: 81g6i5v05i) (mebendazole - unii:81g6i5v05i) - mebendazole 500 mg - vermox™ chewable is indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by ascaris lumbricoides (roundworm) and trichuris trichiura (whipworm). vermox™ chewable is contraindicated in persons with a known hypersensitivity to the drug or its excipients. risk summary the available published literature on mebendazole use in pregnant women has not reported a clear association between mebendazole and a potential risk of major birth defects or miscarriages [see data]. there are risks to the mother and fetus associated with untreated helminthic infection during pregnancy [see clinical considerations] . in animal reproduction studies, adverse developmental effects (i.e., skeletal malformations, soft tissue malformations, decreased pup weight, embryolethality) were observed when mebendazole was administered to pregnant rats during the period of organogenesis at single oral doses as low as 10 mg/kg (approximately 0.2-fold the maximum recommended human dose (mrhd))

USA - engelsk - NLM (National Library of Medicine)

johnson & johnson consumer inc, mcneil consumer healthcare division - mebendazole (unii: 81g6i5v05i) (mebendazole - unii:81g6i5v05i) - mebendazole 100 mg - vermox™ is indicated for the treatment of patients two years of age and older with gastrointestinal infections caused by ancylostoma duodenale (hookworm), ascaris lumbricoides (roundworm), enterobius vermicularis (pinworm), necator americanus (hookworm), and trichuris trichiura (whipworm). vermox™ is contraindicated in persons with a known hypersensitivity to the drug or its excipients. risk summary the available published literature on mebendazole use in pregnant women has not reported a clear association between mebendazole and a potential risk of major birth defects or miscarriages [see data]. there are risks to the mother and fetus associated with untreated helminthic infection during pregnancy [see clinical considerations] . in animal reproduction studies, adverse developmental effects (i.e., skeletal malformations, soft tissue malformations, decreased pup weight, embryolethality) were observed when mebendazole was administered to pregnant rats during the period of organogenesis at single oral dose

Moldova - rumensk - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

gedeon richter plc - mebendazolum - comprimate - 100 mg

Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

janssen-cilag s.p.a. - italia - mebendazolum - compr. - 100mg - antinematode derivati de benzimidazol

Israel - engelsk - Ministry of Health

j-c health care ltd - mebendazole - suspension - mebendazole 20 mg/ml - mebendazole - mebendazole - treatment of single or mixed infections of trichuris trichura (whipworm), ascaris lumbricoides (large roundworm), ancylostoma duodenale, necator americanus (hookworm), strongyloides stercoralis, enterobius vermicularis (threadworm/pinworm) and taenia spp.

Israel - engelsk - Ministry of Health

j-c health care ltd - mebendazole - tablets - mebendazole 100 mg - mebendazole - mebendazole - treatment of trichuris trichiura (whipworm). ascaris lumbricoides (roundworm). ancylostoma duodenale (common hookworm). necator americanus (american hookworm), strongyloidiasis, enterobius vermicularis (pinworm) and teniasis in single or mixed infections.

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - mebendazolum - compresse - mebendazolum 100 mg, cellulosum microcristallinum, carboxymethylamylum natricum una, talco, maydis per amylum, magnesio stearas, gossypii olio hydrogenatum, silice colloidalis anhydrica, natrii laurilsulfas, sono (arance), saccharinum natricum, e 110 60 µg, per compresso corrisp. sodio 3.8 mg. - anthelmintikum - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - mebendazolum - compresse - mebendazolum 500 mg, lactosum monohydricum 34 mg, methylcellulosum, carboxymethylamylum natricum a corresp. natrium 2.23 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, silica colloidalis anhydrica, pro compresso. - anthelmintikum - synthetika

Litauen - litauisk - SMCA (Valstybinė vaistų kontrolės tarnyba)

limedika, uab - mebendazolas - tabletės - 100 mg - mebendazole

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - mebendazolum - comprimés - mebendazolum 100 mg, cellulosum microcristallinum, carboxymethylamylum natricum un, talc, maydis pour amylum, magnésium stearas, gossypii huile hydrogenatum, de la silice colloidalis anhydrica, natrii laurilsulfas, sont (orangen), saccharinum natricum, e 110 60 µg, pour compresso corresp. sodium 3,8 mg. - anthelmintikum - synthetika